1. Antioxidant Enzymes and Their Potential Use in Breast Cancer Treatment.
- Author
-
Vilchis-Landeros MM, Vázquez-Meza H, Vázquez-Carrada M, Uribe-Ramírez D, and Matuz-Mares D
- Subjects
- Humans, Female, Oxidative Stress, Peroxiredoxins metabolism, Animals, Glutathione Peroxidase metabolism, Catalase metabolism, Superoxide Dismutase metabolism, Antioxidants metabolism, Antioxidants therapeutic use, Breast Neoplasms metabolism, Breast Neoplasms drug therapy, Breast Neoplasms pathology, Reactive Oxygen Species metabolism
- Abstract
According to the World Health Organization (WHO), breast cancer (BC) is the deadliest and the most common type of cancer worldwide in women. Several factors associated with BC exert their effects by modulating the state of stress. They can induce genetic mutations or alterations in cell growth, encouraging neoplastic development and the production of reactive oxygen species (ROS). ROS are able to activate many signal transduction pathways, producing an inflammatory environment that leads to the suppression of programmed cell death and the promotion of tumor proliferation, angiogenesis, and metastasis; these effects promote the development and progression of malignant neoplasms. However, cells have both non-enzymatic and enzymatic antioxidant systems that protect them by neutralizing the harmful effects of ROS. In this sense, antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), thioredoxin reductase (TrxR), and peroxiredoxin (Prx) protect the body from diseases caused by oxidative damage. In this review, we will discuss mechanisms through which some enzymatic antioxidants inhibit or promote carcinogenesis, as well as the new therapeutic proposals developed to complement traditional treatments.
- Published
- 2024
- Full Text
- View/download PDF